Literature DB >> 9665479

CD44 isoform expression follows two alternative splicing pathways in breast tissue.

X Roca1, J L Mate, A Ariza, A M Muñoz-Mármol, C von Uexküll-Güldeband, I Pellicer, J J Navas-Palacios, M Isamat.   

Abstract

The repertoire of distinct CD44 protein isoforms is generated by means of alternative pre-mRNA splicing of 10 variable exons located in the central region of the CD44 gene. We have used human breast ductal carcinoma as a model to identify two alternative splicing pathways of the CD44 pre-mRNA variable region that account for the generation of all of the CD44 isoforms described in breast tissue. An alternative splicing pathway that reflects inclusion of variable exons in a gradual 3'-to-5' fashion is evidenced in breast ductal carcinoma and its lymph node metastases. This pathway is compatible with a mechanism that generates the standard form of CD44 (devoid of variable exons) and is distinguishable from an alternative splicing pathway that involves exclusively variant exon 3 and is observable in both normal and carcinoma breast tissue. We show that both pathways are detectable in the same cell type in the breast and provide a speculative model by which these splicing routes could take place.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9665479      PMCID: PMC1852957          DOI: 10.1016/S0002-9440(10)65559-9

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  42 in total

Review 1.  Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation.

Authors:  L A Liotta; P S Steeg; W G Stetler-Stevenson
Journal:  Cell       Date:  1991-01-25       Impact factor: 41.582

2.  Adhesive interactions between alternatively spliced CD44 isoforms.

Authors:  A Droll; S T Dougherty; R K Chiu; J F Dirks; W H McBride; D L Cooper; G J Dougherty
Journal:  J Biol Chem       Date:  1995-05-12       Impact factor: 5.157

3.  Keratan sulfate modification of CD44 modulates adhesion to hyaluronate.

Authors:  K Takahashi; I Stamenkovic; M Cutler; A Dasgupta; K K Tanabe
Journal:  J Biol Chem       Date:  1996-04-19       Impact factor: 5.157

4.  Trans-acting factors regulate the expression of CD44 splice variants.

Authors:  H Konig; J Moll; H Ponta; P Herrlich
Journal:  EMBO J       Date:  1996-08-01       Impact factor: 11.598

5.  A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells.

Authors:  U Günthert; M Hofmann; W Rudy; S Reber; M Zöller; I Haussmann; S Matzku; A Wenzel; H Ponta; P Herrlich
Journal:  Cell       Date:  1991-04-05       Impact factor: 41.582

Review 6.  Are CD44 variant isoforms involved in human tumour progression?

Authors:  U Günthert; R Stauder; B Mayer; H J Terpe; L Finke; K Friedrichs
Journal:  Cancer Surv       Date:  1995

7.  O-linked glycosylation modifies CD44 adhesion to hyaluronate in colon carcinoma cells.

Authors:  A Dasgupta; K Takahashi; M Cutler; K K Tanabe
Journal:  Biochem Biophys Res Commun       Date:  1996-10-03       Impact factor: 3.575

8.  CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer.

Authors:  K Friedrichs; F Franke; B W Lisboa; G Kügler; I Gille; H J Terpe; F Hölzel; H Maass; U Günthert
Journal:  Cancer Res       Date:  1995-11-15       Impact factor: 12.701

9.  The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells.

Authors:  I Stamenkovic; A Aruffo; M Amiot; B Seed
Journal:  EMBO J       Date:  1991-02       Impact factor: 11.598

10.  Identification and characterization of three members of the human SR family of pre-mRNA splicing factors.

Authors:  G R Screaton; J F Cáceres; A Mayeda; M V Bell; M Plebanski; D G Jackson; J I Bell; A R Krainer
Journal:  EMBO J       Date:  1995-09-01       Impact factor: 11.598

View more
  5 in total

1.  CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling.

Authors:  Wei-Hsuan Yu; J Frederick Woessner; John D McNeish; Ivan Stamenkovic
Journal:  Genes Dev       Date:  2002-02-01       Impact factor: 11.361

2.  CD44 functions in Wnt signaling by regulating LRP6 localization and activation.

Authors:  M Schmitt; M Metzger; D Gradl; G Davidson; V Orian-Rousseau
Journal:  Cell Death Differ       Date:  2014-10-10       Impact factor: 15.828

3.  Estrogen induced breast cancer is the result in the disruption of the asymmetric cell division of the stem cell.

Authors:  Jose Russo; Kara Snider; Julia S Pereira; Irma H Russo
Journal:  Horm Mol Biol Clin Investig       Date:  2010-01-01

4.  Multisite and bidirectional exonic splicing enhancer in CD44 alternative exon v3.

Authors:  Elena Vela; Josep M Hilari; Xavier Roca; Ana M Muñoz-Mármol; Aurelio Ariza; Marcos Isamat
Journal:  RNA       Date:  2007-10-16       Impact factor: 4.942

5.  Conservation of CD44 exon v3 functional elements in mammals.

Authors:  Elena Vela; Josep M Hilari; María Delclaux; Hugo Fernández-Bellon; Marcos Isamat
Journal:  BMC Res Notes       Date:  2008-07-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.